LiteFold/IEDB huggingface dataset:
Reference: Bin Zhang; Hongchao Gou; Haiyan Shen; Chunhong Zhang; Zhicheng Liu; Nile Wuri; Jingjing Nie; Yunzhi Qu; Jianfeng Zhang; Letu Geri. "Display of porcine epidemic diarrhea virus spike protein B-cell linear epitope on Lactobacillus mucosae G01 S-layer surface induce a robust immunogenicity in mice." Microbial cell factories (2024).

Epitope: Epitope 1
Chemical type: Peptide from protein
Sequence: SQEPFDPSGY
Position: 96-105
Source molecule (GenBank): S0AP48.1
Assay category: BCell
Result: Positive

Epitope: Epitope 1
Chemical type: Peptide from protein
Sequence: SQEPFDPSGY
Position: 96-105
Source molecule (GenBank): S0AP48.1
Assay category: BCell
Result: Positive

Epitope: Epitope 1
Chemical type: Peptide from protein
Sequence: SQEPFDPSGY
Position: 96-105
Source molecule (GenBank): S0AP48.1
Assay category: BCell
Result: Positive

Epitope: Epitope 1
Chemical type: Peptide from protein
Sequence: SQEPFDPSGY
Position: 96-105
Source molecule (GenBank): S0AP48.1
Assay category: BCell
Result: Positive-High

Epitope: Epitope 1
Chemical type: Peptide from protein
Sequence: SQEPFDPSGY
Position: 96-105
Source molecule (GenBank): S0AP48.1
Assay category: TCell
Result: Positive
Cell type: T cell
Tissue: blood
Culture conditions: Direct Ex Vivo

Epitope: Epitope 1
Chemical type: Peptide from protein
Sequence: SQEPFDPSGY
Position: 96-105
Source molecule (GenBank): S0AP48.1
Assay category: TCell
Result: Positive
Cell type: T cell
Tissue: blood
Culture conditions: Direct Ex Vivo

Epitope: Epitope 1
Chemical type: Peptide from protein
Sequence: SQEPFDPSGY
Position: 96-105
Source molecule (GenBank): S0AP48.1
Assay category: TCell
Result: Negative
Cell type: T cell
Tissue: blood
Culture conditions: Direct Ex Vivo

Epitope: Epitope 1
Chemical type: Peptide from protein
Sequence: SQEPFDPSGY
Position: 96-105
Source molecule (GenBank): S0AP48.1
Assay category: TCell
Result: Negative
Cell type: T cell
Tissue: blood
Culture conditions: Direct Ex Vivo
Reference: Sarah Hulin-Curtis; James K Geary; Bruce J MacLachlan; Danny M Altmann; Laury Baillon; David K Cole; Alex Greenshields-Watson; Sophie J Hesketh; Ian R Humphreys; Ian M Jones; Sarah N Lauder; Georgina H Mason; Kathryn Smart; D Oliver Scourfield; Jake Scott; Ksenia Sukhova; Richard J Stanton; Aaron Wall; Pierre J Rizkallah; Wendy S Barclay; Awen Gallimore; Andrew Godkin. "A targeted single mutation in influenza A virus universal epitope transforms immunogenicity and protective immunity via CD4<sup>+</sup> T cell activation." Cell reports (2024).

Epitope: GLI M1 129-143 V11R
Chemical type: Peptide, no natural source
Sequence: GLIYNRMGAVTTERA
Assay category: TCell
Result: Positive
Host:  29-39 weeks
Cell type: splenocyte
Tissue: spleen
Culture conditions: Direct Ex Vivo
Reference: J Bae; R Prabhala; A Voskertchian; A Brown; C Maguire; P Richardson; G Dranoff; K C Anderson; N C Munshi. "A multiepitope of XBP1, CD138 and CS1 peptides induces myeloma-specific cytotoxic T lymphocytes in T cells of smoldering myeloma patients." Leukemia (2015).

Epitope: MAGE3
Chemical type: Peptide from protein
Sequence: FLWGPRALV
Position: 271-279
Source molecule (GenBank): P43357.1
Assay category: TCell
Result: Positive-Low
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Short Term Restimulated

Epitope: MAGE3
Chemical type: Peptide from protein
Sequence: FLWGPRALV
Position: 271-279
Source molecule (GenBank): P43357.1
Assay category: TCell
Result: Positive-Low
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Short Term Restimulated
Reference: Daniela Fenoglio; Alessia Parodi; Rosa Lavieri; Francesca Kalli; Francesca Ferrera; Augusto Tagliamacco; Andrea Guastalla; Maria Giuseppina Lamperti; Mauro Giacomini; Gilberto Filaci. "Immunogenicity of GX301 cancer vaccine: Four (telomerase peptides) are better than one." Human vaccines & immunotherapeutics (2015).

Epitope: Peptide D (766-780)
Chemical type: Peptide from protein
Sequence: LTDLQPYMRQFVAHL
Position: 766-780
Source molecule (GenBank): O14746.1
Assay category: TCell
Result: Positive
Host:  27-62 years
Cell type: PBMC
Tissue: blood
Culture conditions: Short Term Restimulated

Epitope: Peptide D (766-780)
Chemical type: Peptide from protein
Sequence: LTDLQPYMRQFVAHL
Position: 766-780
Source molecule (GenBank): O14746.1
Assay category: TCell
Result: Positive
Host:  27-62 years
Cell type: T cell CD4+
Tissue: blood
Culture conditions: Short Term Restimulated

Epitope: Peptide D (766-780)
Chemical type: Peptide from protein
Sequence: LTDLQPYMRQFVAHL
Position: 766-780
Source molecule (GenBank): O14746.1
Assay category: TCell
Result: Positive
Host:  27-62 years
Cell type: PBMC
Tissue: blood
Culture conditions: Cell Line / Clone

Epitope: Peptide D (766-780)
Chemical type: Peptide from protein
Sequence: LTDLQPYMRQFVAHL
Position: 766-780
Source molecule (GenBank): O14746.1
Assay category: TCell
Result: Positive
Host:  27-62 years
Cell type: PBMC
Tissue: blood
Culture conditions: Direct Ex Vivo

Epitope: Peptide D (766-780)
Chemical type: Peptide from protein
Sequence: LTDLQPYMRQFVAHL
Position: 766-780
Source molecule (GenBank): O14746.1
Assay category: TCell
Result: Positive
Host:  27-62 years
Cell type: T cell CD4+
Tissue: blood
Culture conditions: Direct Ex Vivo

Epitope: Peptide D (766-780)
Chemical type: Peptide from protein
Sequence: LTDLQPYMRQFVAHL
Position: 766-780
Source molecule (GenBank): O14746.1
Assay category: TCell
Result: Positive
Host:  27-62 years
Cell type: PBMC
Tissue: blood
Culture conditions: Cell Line / Clone
Reference: Chien-Chung Chang; Giuseppe Pirozzi; Shao-Hsuan Wen; I-Hsin Chung; Bau-Lin Chiu; Simona Errico; Monica Luongo; Maria Luisa Lombardi; Soldano Ferrone. "Multiple structural and epigenetic defects in the human leukocyte antigen class I antigen presentation pathway in a recurrent metastatic melanoma following immunotherapy." The Journal of biological chemistry (2015).

Epitope: gp100 17-25
Chemical type: Peptide from protein
Sequence: ALLAVGATK
Position: 17-25
Source molecule (GenBank): F8VUB1.1
Assay category: TCell
Result: Positive
Cell type: PBMC
Tissue: blood
Culture conditions: Short Term Restimulated
Reference: Kathrin Textoris-Taube; Christin Keller; Juliane Liepe; Petra Henklein; John Sidney; Alessandro Sette; Peter M Kloetzel; Michele Mishto. "The T210M Substitution in the HLA-a*02:01 gp100 Epitope Strongly Affects Overall Proteasomal Cleavage Site Usage and Antigen Processing." The Journal of biological chemistry (2015).

Epitope: gp100 207-217
Chemical type: Peptide from protein
Sequence: FTITDQVPFSV
Position: 207-217
Source molecule (GenBank): P40967.2
Assay category: TCell
Result: Positive-High
Cell type: PBMC
Tissue: blood
Culture conditions: Engineered

Epitope: gp100 207-217
Chemical type: Peptide from protein
Sequence: FTITDQVPFSV
Position: 207-217
Source molecule (GenBank): P40967.2
Assay category: TCell
Result: Positive
Cell type: PBMC
Tissue: blood
Culture conditions: Engineered

Epitope: gp100 207-217
Chemical type: Peptide from protein
Sequence: FTITDQVPFSV
Position: 207-217
Source molecule (GenBank): P40967.2
Assay category: MhcBinding
Result: Positive-Low
Quantitative measurement: 60.0

Epitope: gp100 209-217
Chemical type: Peptide from protein
Sequence: ITDQVPFSV
Position: 209-217
Source molecule (GenBank): P40967.2
Assay category: TCell
Result: Positive-Low
Cell type: PBMC
Tissue: blood
Culture conditions: Engineered

Epitope: gp100 209-217
Chemical type: Peptide from protein
Sequence: ITDQVPFSV
Position: 209-217
Source molecule (GenBank): P40967.2
Assay category: TCell
Result: Positive
Cell type: PBMC
Tissue: blood
Culture conditions: Engineered

Epitope: gp100 209-217
Chemical type: Peptide from protein
Sequence: ITDQVPFSV
Position: 209-217
Source molecule (GenBank): P40967.2
Assay category: MhcBinding
Result: Positive-Low
Quantitative measurement: 120.0
Reference: Fitsum G Tadesse; Nadia Mensali; Lars-Egil Fallang; Even Walseng; Weiwen Yang; Johanna Olweus; Sébastien Wälchli. "Unpredicted phenotypes of two mutants of the TcR DMF5." Journal of immunological methods (2015).

Epitope: MART-1 peptide<sub>27-35</sub>
Chemical type: Peptide from protein
Sequence: AAGIGILTV
Position: 27-35
Source molecule (GenBank): Q16655.1
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Engineered

Epitope: MART-1 peptide<sub>27-35</sub>
Chemical type: Peptide from protein
Sequence: AAGIGILTV
Position: 27-35
Source molecule (GenBank): Q16655.1
Assay category: TCell
Result: Positive
Cell type: T cell CD4+
Tissue: blood
Culture conditions: Engineered

Epitope: MART-1 peptide<sub>27-35</sub>
Chemical type: Peptide from protein
Sequence: AAGIGILTV
Position: 27-35
Source molecule (GenBank): Q16655.1
Assay category: TCell
Result: Positive
Quantitative measurement: 5.79
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Engineered

Epitope: MART-1 peptide<sub>27-35</sub>
Chemical type: Peptide from protein
Sequence: AAGIGILTV
Position: 27-35
Source molecule (GenBank): Q16655.1
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Engineered

Epitope: MART-1 peptide<sub>27-35</sub>
Chemical type: Peptide from protein
Sequence: AAGIGILTV
Position: 27-35
Source molecule (GenBank): Q16655.1
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Engineered
Reference: Kazuya Ofuji; Yoshitaka Tada; Toshiaki Yoshikawa; Manami Shimomura; Mayuko Yoshimura; Keigo Saito; Yasunari Nakamoto; Tetsuya Nakatsura. "A peptide antigen derived from EGFR T790M is immunogenic in non‑small cell lung cancer." International journal of oncology (2015).

Epitope: T790M-D
Chemical type: Peptide, no natural source
Sequence: IMQLMPFGV
Assay category: TCell
Result: Negative
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Short Term Restimulated

Epitope: T790M-D
Chemical type: Peptide, no natural source
Sequence: IMQLMPFGV
Assay category: MhcBinding
Result: Positive-High
Reference: Lior Carmon; Irit Avivi; Riva Kovjazin; Tsila Zuckerman; Lillian Dray; Moshe E Gatt; Reuven Or; Michael Y Shapira. "Phase I/II study exploring ImMucin, a pan-major histocompatibility complex, anti-MUC1 signal peptide vaccine, in multiple myeloma patients." British journal of haematology (2015).

Epitope: MUC1-TRA-L
Chemical type: Peptide from protein
Sequence: STAPPAHGVTSAPDTRPAPGSTAPP
Position: 130-154
Source molecule (GenBank): A0A0C4DGW3.1
Assay category: BCell
Result: Positive-Low

Epitope: MUC1-TRA-L
Chemical type: Peptide from protein
Sequence: STAPPAHGVTSAPDTRPAPGSTAPP
Position: 130-154
Source molecule (GenBank): A0A0C4DGW3.1
Assay category: BCell
Result: Positive-Low

Epitope: MUC1-TRA-L
Chemical type: Peptide from protein
Sequence: STAPPAHGVTSAPDTRPAPGSTAPP
Position: 130-154
Source molecule (GenBank): A0A0C4DGW3.1
Assay category: TCell
Result: Positive-Low
Cell type: PBMC
Tissue: blood
Culture conditions: Direct Ex Vivo

Epitope: MUC1-TRA-L
Chemical type: Peptide from protein
Sequence: STAPPAHGVTSAPDTRPAPGSTAPP
Position: 130-154
Source molecule (GenBank): A0A0C4DGW3.1
Assay category: TCell
Result: Positive-Low
Cell type: PBMC
Tissue: blood
Culture conditions: Direct Ex Vivo
Reference: Wuguang Lu; Lingchong Qiu; Zhanpeng Yan; Zhibing Lin; Meng Cao; Chunping Hu; Zhigang Wang; Jin Wang; Ye Yu; Xiaoyang Cheng; Peng Cao; Rongxiu Li. "Cytotoxic T cell responses are enhanced by antigen design involving the presentation of MUC1 peptide on cholera toxin B subunit." Oncotarget (2015).

Epitope: MUC1<sub>30</sub>
Chemical type: Peptide from protein
Sequence: VTSAPDTRPAPGSTAPPAHGVTSAPDTRPA
Position: 138-167
Source molecule (GenBank): P15941.3
Assay category: BCell
Result: Positive
Reference: Simone Kayser; Cristina Boβ; Judith Feucht; Kai-Erik Witte; Alexander Scheu; Hans-Jörg Bülow; Stefanie Joachim; Stefan Stevanović; Michael Schumm; Susanne M Rittig; Peter Lang; Martin Röcken; Rupert Handgretinger; Tobias Feuchtinger. "Rapid generation of NY-ESO-1-specific CD4<sup>+</sup> T<sub>HELPER</sub>1 cells for adoptive T-cell therapy." Oncoimmunology (2015).

Epitope: NY-ESO-1 85-99
Chemical type: Peptide from protein
Sequence: SRLLEFYLAMPFATP
Position: 85-99
Source molecule (GenBank): CAA05908.1
Assay category: TCell
Result: Positive
Host: F 43 years
Cell type: PBMC
Tissue: blood
Culture conditions: Short Term Restimulated

Epitope: NY-ESO-1 85-99
Chemical type: Peptide from protein
Sequence: SRLLEFYLAMPFATP
Position: 85-99
Source molecule (GenBank): CAA05908.1
Assay category: TCell
Result: Positive
Host: F 43 years
Cell type: PBMC
Tissue: blood
Culture conditions: Short Term Restimulated

Epitope: NY-ESO-1 85-99
Chemical type: Peptide from protein
Sequence: SRLLEFYLAMPFATP
Position: 85-99
Source molecule (GenBank): CAA05908.1
Assay category: TCell
Result: Positive
Host: F 43 years
Cell type: PBMC
Tissue: blood
Culture conditions: Short Term Restimulated
Reference: Yoshihiro Yoshitake; Daiki Fukuma; Akira Yuno; Masatoshi Hirayama; Hideki Nakayama; Takuya Tanaka; Masashi Nagata; Yasuo Takamune; Kenta Kawahara; Yoshihiro Nakagawa; Ryoji Yoshida; Akiyuki Hirosue; Hidenao Ogi; Akimitsu Hiraki; Hirofumi Jono; Akinobu Hamada; Koji Yoshida; Yasuharu Nishimura; Yusuke Nakamura; Masanori Shinohara. "Phase II clinical trial of multiple peptide vaccination for advanced head and neck cancer patients revealed induction of immune responses and improved OS." Clinical cancer research : an official journal of the American Association for Cancer Research (2015).

Epitope: LY6K-177
Chemical type: Peptide from protein
Sequence: RYCNLEGPPI
Position: 119-128
Source molecule (GenBank): Q17RY6.2
Assay category: TCell
Result: Positive
Host:  36-85 years
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Direct Ex Vivo

Epitope: LY6K-177
Chemical type: Peptide from protein
Sequence: RYCNLEGPPI
Position: 119-128
Source molecule (GenBank): Q17RY6.2
Assay category: TCell
Result: Positive
Host:  36-85 years
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Direct Ex Vivo

Epitope: LY6K-177
Chemical type: Peptide from protein
Sequence: RYCNLEGPPI
Position: 119-128
Source molecule (GenBank): Q17RY6.2
Assay category: TCell
Result: Positive
Host:  36-85 years
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Short Term Restimulated
Reference: E Yamada; A Demachi-Okamura; S Kondo; Y Akatsuka; S Suzuki; K Shibata; F Kikkawa; K Kuzushima. "Identification of a naturally processed HLA-Cw7-binding peptide that cross-reacts with HLA-A24-restricted ovarian cancer-specific CTLs." Tissue antigens (2015).

Epitope: EKH 665-673
Chemical type: Peptide from protein
Sequence: EKHQVYPEY
Position: 665-673
Source molecule (GenBank): Q9H0J9.1
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Cell Line / Clone
Reference: Claudia Paret; Petra Simon; Kirsten Vormbrock; Christian Bender; Anne Kölsch; Andrea Breitkreuz; Özlem Yildiz; Tana Omokoko; Stefanie Hubich-Rau; Christoph Hartmann; Sabine Häcker; Meike Wagner; Diana Barea Roldan; Abderaouf Selmi; Özlem Türeci; Ugur Sahin. "CXorf61 is a target for T cell based immunotherapy of triple-negative breast cancer." Oncotarget (2015).

Epitope: CXorf61 66-74
Chemical type: Peptide from protein
Sequence: ILNNFPHSI
Position: 66-74
Source molecule (GenBank): Q5H943.1
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Short Term Restimulated

Epitope: CXorf61 66-74
Chemical type: Peptide from protein
Sequence: ILNNFPHSI
Position: 66-74
Source molecule (GenBank): Q5H943.1
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Cell Line / Clone

Epitope: CXorf61 66-74
Chemical type: Peptide from protein
Sequence: ILNNFPHSI
Position: 66-74
Source molecule (GenBank): Q5H943.1
Assay category: TCell
Result: Positive-Low
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Cell Line / Clone

Epitope: CXorf61 66-74
Chemical type: Peptide from protein
Sequence: ILNNFPHSI
Position: 66-74
Source molecule (GenBank): Q5H943.1
Assay category: TCell
Result: Positive-Low
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Cell Line / Clone

Epitope: CXorf61 66-74
Chemical type: Peptide from protein
Sequence: ILNNFPHSI
Position: 66-74
Source molecule (GenBank): Q5H943.1
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Short Term Restimulated

Epitope: CXorf61 66-74
Chemical type: Peptide from protein
Sequence: ILNNFPHSI
Position: 66-74
Source molecule (GenBank): Q5H943.1
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Cell Line / Clone

Epitope: CXorf61 66-74
Chemical type: Peptide from protein
Sequence: ILNNFPHSI
Position: 66-74
Source molecule (GenBank): Q5H943.1
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Short Term Restimulated

Epitope: CXorf61 66-74
Chemical type: Peptide from protein
Sequence: ILNNFPHSI
Position: 66-74
Source molecule (GenBank): Q5H943.1
Assay category: TCell
Result: Positive
Cell type: splenocyte
Tissue: spleen
Culture conditions: Direct Ex Vivo

Epitope: CXorf61 79-87
Chemical type: Peptide from protein
Sequence: RILVNLSMV
Position: 79-87
Source molecule (GenBank): Q5H943.1
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Cell Line / Clone

Epitope: CXorf61 79-87
Chemical type: Peptide from protein
Sequence: RILVNLSMV
Position: 79-87
Source molecule (GenBank): Q5H943.1
Assay category: TCell
Result: Positive-Low
Cell type: splenocyte
Tissue: spleen
Culture conditions: Direct Ex Vivo
Reference: Weihong Sun; Xiaofang Wei; Airong Niu; Xuezhen Ma; Jian Jian Li; Daiqing Gao. "Enhanced anti-colon cancer immune responses with modified eEF2-derived peptides." Cancer letters (2015).

Epitope: 1Y3W7W
Chemical type: Peptide, no natural source
Sequence: YLWEPIWLV
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Short Term Restimulated

Epitope: 1Y3W7W
Chemical type: Peptide, no natural source
Sequence: YLWEPIWLV
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Short Term Restimulated

Epitope: 1Y3W7W
Chemical type: Peptide, no natural source
Sequence: YLWEPIWLV
Assay category: TCell
Result: Positive-High
Cell type: splenocyte
Tissue: spleen
Culture conditions: Short Term Restimulated

Epitope: 1Y3W7W
Chemical type: Peptide, no natural source
Sequence: YLWEPIWLV
Assay category: TCell
Result: Positive
Cell type: splenocyte
Tissue: spleen
Culture conditions: Short Term Restimulated

Epitope: 1Y3W7W
Chemical type: Peptide, no natural source
Sequence: YLWEPIWLV
Assay category: TCell
Result: Positive
Cell type: splenocyte
Tissue: spleen
Culture conditions: Short Term Restimulated

Epitope: 1Y3W7W
Chemical type: Peptide, no natural source
Sequence: YLWEPIWLV
Assay category: MhcBinding
Result: Positive

Epitope: 7W
Chemical type: Peptide, no natural source
Sequence: RLMEPIWEV
Assay category: MhcBinding
Result: Positive
Reference: Jason Brayer; Jeffrey E Lancet; John Powers; Alan List; Lodovico Balducci; Rami Komrokji; Javier Pinilla-Ibarz. "WT1 vaccination in AML and MDS: A pilot trial with synthetic analog peptides." American journal of hematology (2015).

Epitope: WT1
Chemical type: Peptide from protein
Sequence: RMFPNAPYL
Position: 126-134
Source molecule (GenBank): P19544.2
Assay category: TCell
Result: Positive
Host: F 72-76 years
Cell type: T cell CD3+
Tissue: blood
Culture conditions: Short Term Restimulated

Epitope: WT1
Chemical type: Peptide from protein
Sequence: RMFPNAPYL
Position: 126-134
Source molecule (GenBank): P19544.2
Assay category: TCell
Result: Positive
Host: F 72-76 years
Cell type: T cell CD3+
Tissue: blood
Culture conditions: Short Term Restimulated

Epitope: WT1
Chemical type: Peptide from protein
Sequence: RMFPNAPYL
Position: 126-134
Source molecule (GenBank): P19544.2
Assay category: TCell
Result: Positive
Cell type: T cell CD3+
Tissue: blood
Culture conditions: Short Term Restimulated

Epitope: WT1
Chemical type: Peptide from protein
Sequence: RMFPNAPYL
Position: 126-134
Source molecule (GenBank): P19544.2
Assay category: TCell
Result: Positive
Cell type: T cell CD3+
Tissue: blood
Culture conditions: Short Term Restimulated

Epitope: WT1
Chemical type: Peptide from protein
Sequence: RMFPNAPYL
Position: 126-134
Source molecule (GenBank): P19544.2
Assay category: TCell
Result: Positive
Cell type: T cell CD3+
Tissue: blood
Culture conditions: Short Term Restimulated
Reference: Shigetaka Shimodaira; Kenji Sano; Koichi Hirabayashi; Terutsugu Koya; Yumiko Higuchi; Yumiko Mizuno; Naoko Yamaoka; Miki Yuzawa; Takashi Kobayashi; Kenichi Ito; Tomonobu Koizumi. "Dendritic Cell-Based Adjuvant Vaccination Targeting Wilms' Tumor 1 in Patients with Advanced Colorectal Cancer." Vaccines (2015).

Epitope: WT1 126
Chemical type: Peptide from protein
Sequence: RMFPNAPYL
Position: 126-134
Source molecule (GenBank): P19544.2
Assay category: TCell
Result: Negative
Cell type: PBMC
Tissue: blood
Culture conditions: Direct Ex Vivo
Reference: Taojun He; Yilin Deng; Fang Zhang; Jin Zhang; Luhong Zhu; Qinjin Wang; Jie Ning; Hui Wu; Hanmei Yuan; Bin Li; Chao Wu. "Characteristics of Norovirus capsid protein-specific CD8<sup>+</sup> T-Cell responses in previously infected individuals." Virulence (2024).

Epitope: P29
Chemical type: Peptide from protein
Sequence: NQSNDSTIKLIAMLYTPL
Position: 169-186
Source molecule (GenBank): YP_009518842.1
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Short Term Restimulated

Epitope: P13
Chemical type: Peptide from protein
Sequence: KLQQEMMKVKQAMLLEGG
Position: 73-90
Source molecule (GenBank): YP_009518843.1
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Short Term Restimulated

Epitope: P15
Chemical type: Peptide from protein
Sequence: MLLEGGFSETDAARGAIN
Position: 85-102
Source molecule (GenBank): YP_009518843.1
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Short Term Restimulated

Epitope: P26
Chemical type: Peptide from protein
Sequence: PARGPSNKSSNSSTATSV
Position: 151-168
Source molecule (GenBank): YP_009518843.1
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Short Term Restimulated

Epitope: VP1<sub>141-148</sub>
Chemical type: Peptide from protein
Sequence: FPHIIVDV
Position: 141-148
Source molecule (GenBank): YP_009518842.1
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Short Term Restimulated

Epitope: VP1<sub>141-148</sub>
Chemical type: Peptide from protein
Sequence: FPHIIVDV
Position: 141-148
Source molecule (GenBank): YP_009518842.1
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Short Term Restimulated
Reference: Mathias Lutz; Andrea Worschech; Miriam Alb; Sabine Gahn; Laura Bernhard; Michael Schwab; Stefanie Obermeier; Hermann Einsele; Ulrike Kämmerer; Peter Heuschmann; Erdwine Klinker; Christoph Otto; Stephan Mielke. "Boost and loss of immune responses against tumor-associated antigens in the course of pregnancy as a model for allogeneic immunotherapy." Blood (2015).

Epitope: WT1 126-134
Chemical type: Peptide from protein
Sequence: RMFPNAPYL
Position: 126-134
Source molecule (GenBank): P19544.2
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Short Term Restimulated

Epitope: WT1 126-134
Chemical type: Peptide from protein
Sequence: RMFPNAPYL
Position: 126-134
Source molecule (GenBank): P19544.2
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Short Term Restimulated

Epitope: WT1 126-134
Chemical type: Peptide from protein
Sequence: RMFPNAPYL
Position: 126-134
Source molecule (GenBank): P19544.2
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Direct Ex Vivo